drugset / Trial / NCT02916745

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

NCT02916745

Phase 1 Completed 5 enrolled Concordia Laboratories Inc.
NaSingle-groupOpen-labelTreatment

Summary

This research study is being conducted to assess the safety and feasibility of using a new developed bronchoscopic technology called electronavigational bronchoscopy to treat subjects with solid tumor in peripheral lung, who are inoperable or refused surgery. It will involve 10 sites in USA and Canada. Participation will last 6 months.

Timeline

Start
2017-01-26
Primary completion
2019-04-12
Completion
2019-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule 2 mg/kg Intravenous